FDA Inspection 1251337 - Wuhan Hongren Biopharmaceutical Inc. - September 04, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Wuhan Hongren Biopharmaceutical Inc., with an inspection on September 4, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Wuhan Hongren Biopharmaceutical Inc.
Inspection Date: September 4, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations

Open in Dashboard

ID · 3d97762a-976d-4d9b-a61b-19099401db0d